Sensei Biotherapeutics, Inc. (SNSE)
30.81
+1.59
(+5.44%)
USD |
NASDAQ |
Apr 17, 16:00
30.81
0.00 (0.00%)
After-Hours: 16:47
Sensei Biotherapeutics Enterprise Value : 13.81M for April 16, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Johnson & Johnson | 594.15B |
| Vir Biotechnology, Inc. | 1.280B |
| Acurx Pharmaceuticals, Inc. | -1.215M |
| Tango Therapeutics, Inc. | 3.263B |
| Xilio Therapeutics, Inc. | -82.29M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -4.569M |
| Total Expenses (Quarterly) | 4.569M |
| EPS Diluted (Quarterly) | -3.622 |
| Earnings Yield | -45.39% |
| Normalized Earnings Yield | -43.67 |